Results 171 to 180 of about 89,994 (247)

The Prognostic and Biological Value of PGF‐Based H&E Pathomics in Hepatocellular Carcinoma

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Purpose Placental growth factor (PGF) is associated with the progression of hepatocellular carcinoma (HCC), but current research on this relationship remains limited. This study aims to establish a pathomics model for predicting PGF expression levels in H&E‐stained HCC sections, and to explore its prognostic relevance and underlying molecular ...
Long Chen, Xusheng Zhang, Kejun Liu, Weihu Ma, Ling Ding, Shicai Liang, Xuebo Wang, Bendong Chen   +7 more
wiley   +1 more source

Multi‐Omics and Machine Learning‐Uncovered FLT1‐Mediated Epithelial‐Endothelial Crosstalk in Cellular Senescence Driving Clear Cell Renal Cell Carcinoma Malignancy

The FASEB Journal, Volume 40, Issue 8, 30 April 2026.
This study integrates multi‐omics data and machine learning to reveal FLT1 as a central mediator of epithelial‐endothelial crosstalk in clear cell renal cell carcinoma (ccRCC). We demonstrate that FLT1‐associated signaling promotes a senescence‐enriched tumor microenvironment, driving malignant progression. Spatial and single‐cell analyses confirm FLT1
Mouyuan Sun, Huchao Mao, Yaxian Luo, Mei Yang, Zhixu He, Shuangyang Li, Zhichao Liu, Lianjie Peng, Quanjie Zhang, Jingyu Zhang, Yan Zhang   +10 more
wiley   +1 more source

Renal-Limited Anti-GBM Disease in Dual-Antibody Positive RPGN: A Case Report. [PDF]

J Brown Hosp Med
Guo W, O'Donnell M.
europepmc   +1 more source

Clinicopathological features and predictors of anti-GBM disease combined with membranous nephropathy. [PDF]

Clin Kidney J
Wu Y, Zhang L, Zhao Z.
europepmc   +1 more source

A case of relapsing anti-GBM disease secondary to alemtuzumab therapy. [PDF]

CEN Case Rep
Leibowitz SM, Manickam V, Srivastava V, Kan G.   +3 more
europepmc   +1 more source

Clinical characteristics of anti-GBM disease with thrombotic microangiopathy: a case report and literature review. [PDF]

CEN Case Rep
Nakamura Y, Kato N, Tatematsu Y, Arai Y, Mori N, Shibata K, Yamazaki M, Yasui H, Fujiwara S, Yamakawa T, Maruyama S.   +10 more
europepmc   +1 more source

Recurrent anti-GBM disease with T-cell large granular lymphocytic leukemia: A case report. [PDF]

Medicine (Baltimore), 2019
Zhang M, Guan N, Zhu P, Chen T, Liu S, Hao C, Xue J.   +6 more
europepmc   +1 more source

Clustering of Anti-GBM Disease: Clues to an Environmental Trigger? [PDF]

Clin J Am Soc Nephrol, 2016
McAdoo SP, Pusey CD.
europepmc   +1 more source

Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease. [PDF]

Front Immunol, 2019
Gray PE, McCarthy H, Siggs OM, Saleem MA, O' Brien T, Frith K, Ziegler JB, Kitching AR, Fogo AB, Hudson BG, Pedchenko V.   +10 more
europepmc   +1 more source

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence [PDF]

, 2018
Badiyan, Shahed N, Cai, Chunyu, Huang, Jiayi, Khwaja, Shariq S, Wang, Xiaowei   +4 more
core   +1 more source